ARCHIVES

FDA, NCI Remain At Odds Over Drug approval Guidelines Despite Reconciliation Discussion

This article is from The Cancer Letter archive.

Vol. 13 No. 39 | October 9, 1987

Download PDF Visit The Full Archive

Related Articles

NIH Advisors Urge Stronger Peer Review, Clinical Center Renewal

May 20, 1994

Senate Gives NIH Director Authority To Permit Research By Unconventional MDs

September 25, 1992

New Opportunities Still Abound In Immunology Program, Terry and other NCI Executives Say

February 27, 1976

Major New Grant Programs Approved In Carcinogenesis, Chemoprevention

May 9, 1980

Centers Network Release “Version 1.0” Of Clinical Guidelines for Eight Cancers

March 15, 1996

ODAC Reviews Post-Marketing Studies for Eight Indications

March 21, 2003